PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2101957
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2101957
The Global OTC Continuous Glucose Monitoring Market was valued at USD 528.2 million in 2025 and is estimated to grow at a CAGR of 17.1% to reach USD 2.5 billion by 2035.

The OTC continuous glucose monitoring market is gaining strong traction as consumers increasingly seek convenient and accessible solutions for tracking metabolic health. OTC CGM systems are wearable glucose monitoring devices that can be purchased and used without a prescription, allowing broader access to continuous glucose tracking. While these technologies have traditionally supported diabetes management, their applications are expanding toward preventive health monitoring among individuals interested in understanding and improving their metabolic wellness. The growing acceptance of proactive healthcare practices, combined with rising consumer awareness, is accelerating adoption among diabetic, prediabetic, and health-focused populations. Technological improvements in sensor accuracy, device miniaturization, longer usage periods, and connectivity with smartphones and wearable platforms are further enhancing the user experience. These advancements are making OTC CGM devices more practical, convenient, and appealing for wider consumer adoption, supporting market expansion over the forecast period.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $528.2 Million |
| Forecast Value | $2.5 Billion |
| CAGR | 17.1% |
The sensors segment held 91% share in 2025. The leading position of sensors is supported by increasing demand for compact, wearable, and easy-to-use health monitoring solutions. As consumers prioritize continuous and non-invasive health tracking, advanced sensor technologies have become the central component of OTC CGM systems. Growing preference for lightweight, comfortable, and minimally disruptive monitoring devices is encouraging greater sensor adoption among both individuals managing glucose conditions and users focused on preventive health.
The prediabetic and at-risk individuals segment captured notable share in 2025. Rising cases of prediabetes and impaired glucose regulation worldwide are contributing significantly to the growth of this segment. Increasing concerns related to lifestyle-related health risks are encouraging consumers to adopt early monitoring solutions that help track glucose patterns and support better health decisions. The growing emphasis on preventive healthcare, early intervention, and personalized wellness management is further strengthening demand for OTC CGM devices among individuals with elevated diabetes risk.
North America OTC Continuous Glucose Monitoring Market held 53.9% share in 2025. The region, led by the U.S., represents a major market for OTC continuous glucose monitoring (CGM) devices due to increasing consumer interest in preventive healthcare, metabolic tracking, and personalized wellness solutions. Growing adoption among non-diabetic users, including individuals focused on fitness and proactive health management, is transforming CGMs from traditional medical monitoring tools into broader lifestyle-oriented health devices, thereby expanding the overall market opportunity.
Prominent players operating in the Global OTC continuous glucose monitoring industry include: Veri, Abbott, Levels Health, Dexcom, Zoe, January AI, Nutrisense, Sinocare, Ultrahuman Healthcare, Supersapiens, and Limbo (Vitals in View). Companies operating in the OTC continuous glucose monitoring market are strengthening their market position through product innovation, technology improvements, strategic partnerships, and expansion of consumer-focused health solutions. Leading participants are investing in advanced sensor technologies, improved data analytics platforms, and seamless digital integrations to enhance device performance and user engagement. Companies are also focusing on developing more affordable, accessible, and user-friendly CGM solutions to reach broader consumer groups. Expanding direct-to-consumer strategies, strengthening mobile health ecosystems, and improving personalized insights are becoming important approaches for gaining market share.